A. V. Hoffbrand - Concepedia

Author

A. V. Hoffbrand

Also Known As

A V Hoffbrand, A Victor Hoffbrand, A. V. HOFFBRAND, A. V. Hoffbrand, A. Victor HOFFBRAND, A. Victor Hoffbrand, A.V Hoffbrand, A.V. HOFFBRAND, A.V. Hoffbrand, A.Victor Hoffbrand

357

Publications

13K

Citations

H-Index

188

Concepts

All Affiliations

University College London The Royal Free Hospital Houston Methodist

About

A. V. Hoffbrand is an author at University College London specializing in medicine, hematology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	42	101	6.3K
2	Health Sciences	19	21	1.6K
3	Natural Sciences	10	10	702
4	Arts	1	1	30
5	Public Health	1	1	167

A. V. Hoffbrand

189

Publications

11.7K

Citations

H-Index

Page 1

	Year	Citations
DEPLETION OF T LYMPHOCYTES IN DONOR MARROW PREVENTS SIGNIFICANT GRAFT-VERSUS-HOST DISEASE IN MATCHED ALLOGENEIC LEUKAEMIC MARROW TRANSPLANT RECIPIENTS H. G. Prentice, George Janossy, L. Price-Jones, The Lancet TransplantationMarrow TransplantationMedicineStem Cell TransplantationImmunology	1984	359
Human bone marrow stromal cells prevent apoptosis and support the survival of chronic lymphocytic leukaemia cells <i>in vitro</i> Panayiotis Panayiotidis, Dylan T. Jones, K. Ganeshaguru, British Journal of Haematology	1996	297
TUMOUR NECROSIS FACTOR AS AN AUTOCRINE TUMOUR GROWTH FACTOR FOR CHRONIC B-CELL MALIGNANCIES F. T. Cordingley, A. V. Hoffbrand, HE Heslop, The Lancet Tumour Necrosis FactorAutoantibody ProductionMalignant Blood DisorderImmunologyPathology	1988	278
Interferon gamma inhibits apoptotic cell death in B cell chronic lymphocytic leukemia. Michael Buschle, Dario Campana, Simon R. Carding, The Journal of Experimental Medicine	1993	249
Hepatic iron concentration combined with long‐term monitoring of serum ferritin to predict complications of iron overload in thalassaemia major Paul Telfer, E. Prestcott, Sally Holden, British Journal of Haematology Heart FailureIron MetabolismPathologyClinical ComplicationsIron Deficiency	2000	240
IMMUNE DONORS CAN PROTECT MARROW-TRANSPLANT RECIPIENTS FROM SEVERE CYTOMEGALOVIRUS INFECTIONS Jean‐Jacques Grob, H. G. Prentice, A. V. Hoffbrand, The Lancet VaccinationTransplantationImmunologyGraft SurvivalBlood Transplantation	1987	232
USE OF ANTI-T-CELL MONOCLONAL ANTIBODY OKT3 TO PREVENT ACUTE GRAFT-VERSUS-HOST DISEASE IN ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR ACUTE LEUKAEMIA H. G. Prentice, George Janossy, D. Skeggs, The Lancet Cell TherapyTransplantationAutoimmune DiseaseMarrow TransplantationStem Cell Transplantation	1982	217
Long-Term Trial of Deferiprone in 51 Transfusion-Dependent Iron Overloaded Patients A. V. Hoffbrand, F. N. Al‐Refaie, Bernard A. Davis, Blood	1998	205
Hepatic iron stores and markers of iron overload in alcoholics and patients with idiopathic hemochromatosis Roger W. Chapman, Marsha Y. Morgan, M Laulicht, Digestive Diseases and Sciences Hepatic Iron StoresHepatologyHeme HomeostasisLiver PhysiologyIron Overload	1982	202
Effective chelation of iron in beta thalassaemia with the oral chelator 1,2-dimethyl-3-hydroxypyrid-4-one. George J. Kontoghiorghes, M. A. Aldouri, A. V. Hoffbrand, BMJ Iron MetabolismPharmacotherapyOral Chelator 1,2-Dimethyl-3-hydroxypyrid-4-oneRedox BiologyMedicinal Chemistry	1987	190

Page 1